JO
LUNG icon

John Overdeck’s Pulmonx LUNG Stock Holding History

John Overdeck’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$113K Buy
86,575
+17,963
+26% +$24.7K ﹤0.01% 4875
2026
Q1 		$88.5K Sell
68,612
-64,158
-48% -$106K ﹤0.01% 4401
2025
Q4 		$293K Buy
132,770
+86,314
+186% +$162K ﹤0.01% 3582
2025
Q3 		$75.3K Buy
46,456
+15,557
+50% +$32.5K ﹤0.01% 3504
2025
Q2 		$80K Sell
30,899
-123,882
-80% -$489K ﹤0.01% 3020
2025
Q1 		$1.04M Buy
154,781
+126,806
+453% +$898K ﹤0.01% 2150
2024
Q4 		$190K Buy
27,975
+534
+2% +$3.52K ﹤0.01% 2881
2024
Q3 		$227K Sell
27,441
-37,048
-57% -$268K ﹤0.01% 2770
2024
Q2 		$409K Sell
64,489
-26,746
-29% -$206K ﹤0.01% 2460
2024
Q1 		$846K Sell
91,235
-77,705
-46% -$911K ﹤0.01% 2054
2023
Q4 		$2.15M Sell
168,940
-7,651
-4% -$79.7K ﹤0.01% 1480
2023
Q3 		$1.82M Sell
176,591
-84,045
-32% -$973K ﹤0.01% 1469
2023
Q2 		$3.42M Sell
260,636
-44,635
-15% -$546K 0.01% 1109
2023
Q1 		$3.41M Buy
305,271
+172,493
+130% +$1.7M 0.01% 1086
2022
Q4 		$1.12M Buy
132,778
+52,028
+64% +$495K ﹤0.01% 1638
2022
Q3 		$1.34M Sell
80,750
-61,761
-43% -$1.14M ﹤0.01% 1339
2022
Q2 		$2.1M Buy
142,511
+113,676
+394% +$2.34M 0.01% 1177
2022
Q1 		$715K Buy
+28,835
New +$745K ﹤0.01% 1851
2021
Q4 		– Sell
-141,372
Closed -$5.09M – 4609
2021
Q3 		$5.09M Buy
141,372
+124,972
+762% +$4.92M 0.01% 1212
2021
Q2 		$724K Buy
+16,400
New +$714K ﹤0.01% 2775

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ECM
ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

John Overdeck's LUNG Position: Q2 2026 in Review

John Overdeck increased its Pulmonx (LUNG) stake by 26% in Q2 2026, buying an estimated $24.7K and bringing the position to 86,575 shares worth $113K. The position accounts for ﹤0.01% of the portfolio, ranked #4875.

John Overdeck first reported a position in LUNG in Q2 2021 and has held it in 20 quarters since. The position peaked at $5.09M in Q3 2021. 108 funds tracked by Wall St. Rank hold LUNG as of Q2 2026.

  • John Overdeck held 86,575 shares of Pulmonx worth $113K as of Q2 2026.
  • John Overdeck bought 17,963 Pulmonx shares in Q2 2026, an estimated $24.7K.
  • Pulmonx made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #4875 holding.
  • John Overdeck first reported a position in Pulmonx in Q2 2021 and has held it in 20 quarters since.
  • John Overdeck's Pulmonx position peaked at $5.09M in Q3 2021.
  • 108 funds tracked by Wall St. Rank held Pulmonx as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.